Research output per year
Research output per year
Search results
-
2020
Development of a molecular therapy for the SOD1 familial variant of ALS
Smith, R. A., Miller, T., Cleveland, D. & Bennett, F., Jan 1 2020, Neurotherapeutics in the Era of Translational Medicine. Elsevier, p. 1-18 18 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
2019
Stable Isotope Labeling Kinetics in CNS Translational Medicine: Introduction to SILK Technology
Bateman, R. J., West, T., Yarasheski, K., Patterson, B. W., Lucey, B., Cirrito, J. R., Lehmann, S., Hirtz, C., Gabelle, A., Miller, T., Barthelemy, N., Sato, C., Bollinger, J. G., Kotzbauer, P. & Paumier, K., 2019, Handbook of Behavioral Neuroscience. Elsevier B.V., p. 173-190 18 p. (Handbook of Behavioral Neuroscience; vol. 29).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
3 Scopus citations -
2016
Antisense oligonucleotides for amyotrophic lateral sclerosis
Self, W. K. & Miller, T. M., Jan 1 2016, Translational Neuroscience: Fundamental Approaches for Neurological Disorders. Springer US, p. 99-109 11 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
2007
Targeting neurological disorders with antisense oligonucleotides
Smith, R. A. & Miller, T. M., Jan 1 2007, Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition. CRC Press, p. 721-745 25 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
2 Scopus citations